Sfoglia per Autore
Sex determination and differentiation in Asparagus officinalis L
1991 M. Bracale, E. Caporali, M.G. Galli, C. Longo, G. Marziani-Longo, G. Rossi, A. Spada, C. Soave, A. Falavigna, F. Raffaldi, E. Maestri, F.M. Restivo, F. Tassi
Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571
2000 C. Gambacorti-Passerini, R. Barni, P. le Coultre, M. Zucchetti, G. Cabrita, L .Cleris, F. Rossi, E. Gianazza, J. Brueggen, P. Pioltelli, E. Pogliani, G. M. Corneo, F. Formelli, M. D’Incalci
STI571 administered to chronic myeloid leukemia (CML) patients inhibits cell proliferation, induces apoptosis and initially causes partial inhibition of BCR/ABL autophosphorylation
2000 C. Gambacorti Passerini, M. Verga, F. Rossi, L. Tornaghi, S. Bungaro, H. Ruchatz, F. Rossi, P. Pioltelli, E. Pogliani, E. Garattini, R. Capdeville, M. D'Incalci, G. Corneo
Alpha 1 acid glycoprotein (AGP) binds to STI571 and alters its tissue distribution and intracellular concentrations
2000 C. Gambacorti Passerini, M. Zucchetti, L. Cleris, F. Rossi, E. Pogliani, G. Corneo, F. Formelli, M. D'Incalci
Sensitivity to the abl inhibitor STI571 in fresh leukaemic cells obtained from chronic myelogenous leukaemia patients in different stages of diesease
2001 C. Gambacorti Passerini, R. Barni, E. Marchesi, M. Verga, F. Rossi, F. Rossi, P. Pioltelli, E. Pogliani, G. Corneo
Differences between In Vivo and In Vitro Sensitivity to Imatinib of Bcr/Abl+ Cells Obteined from Leukemic Patients
2002 C. Gambacorti Passerini, F. Rossi, M. Verga, H. Richatz, R. Gunby, R. Frapolli, M. Zucchetti, L. Scapozza, S. Bungaro, L. Tornaghi, F. Rossi, P. Pioltelli, E. Pogliani, M. D'Incalci, G. Corneo
Alpha1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patients
2003 C. Gambacorti Passerini, M. Zucchetti, D. Russo, R. Frapolli, M. Verga, S. Bungaro, L. Tornaghi, F. Rossi, P. Pioltelli, E. Pogliani, D. Alberti, G. Corneo, M. D'Incalci
Second malignancies in essential thrombocytosis : a retrospective analysis of 331 patients from a single institution
2005 F. Radaelli, F.G. Rossi, F. Onida, M.C. Pasquini, P. Usardi, R. Calori, A. Zanella
Treatment with hydroxyurea as single agent does not increase the risk of second malignancies in essential thrombocytopenia patients
2006 F. Radaelli, F. Onida, F. Rossi, M. Colombi, V.R. Zilioli, F. Somalvico, A. Zanella
Front-line treatment of low-grade non-follicular non-hodgkin lymphoma : final report of GISL LL02 trial
2007 M. Goldaniga, F. Merli, C. Stelitano, V. Callea, F. Ilariucci, M. Russo, P. Mazza, S. Luminari, F. Rossi, M. Brugiatelli, D. Luisi, B. Olivero, G. Lambertenghi Deliliers, M. Federico, L. Baldini
Final report 50F GISL LL02 trials for thr treatment of low-grade non- follicular non- Hodgkin lymphoma, at diagnosis
2007 M. Goldaniga, M. Merli, F. Callea, F. Ilariucci, C. Stelitano, M. Russo, P. Mazza, S. Luminari, M. Brugiatelli, D. Luisi, F. Rossi, B. Olivero, G. Lambertenghi Deliliers, M. Federico, L. Baldini
Low risk IgG Monoclonal Gammopathy of undetermined significance (MGUS) : proposal and validation of a prognostic scoring system
2007 F.G. Rossi, L. Marcheselli, D. Rossi, V. Callea, A. Guffanti, V. Federico, M. De Muro, A. Baraldi, P. Musto, A. Bacigalupo, G. Gaidano, M.T. Petrucci, M. Goldaniga, L. De Paoli, L. Baldini
Diagnostic Role of Flow Cytometry Analysis of Bioptical Samples in the Diagnosis of Lymphoid Tumors
2008 L. Cro, A. Ferrario, N. Zucal, U. Gianelli, S. Fabris, L. Nobili, B. Olivero, F.G. Rossi, L. Baldini, G. Lambertenghi Deliliers
IgG and IgA Monoclonal Gammopathies of Undetermined Significance (MGUS) at Low Risk of Evolution : Proposal and Validation of a Prognostic Scoring System
2008 F.G. Rossi, L. Marcheselli, M.T. Petrucci, D. Rossi, V. Callea, A. Guffanti, M. De Muro, V. Federico, A. Baraldi, P. Musto, A. Bacigalupo, G. Gaidano, M. Goldaniga, G. Avvisati, G. Lambertenghi Deliliers, L. Baldini
A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias
2008 M. Goldaniga, A. Ferrario, S. Cortelazzo, A. Guffanti, E. Pavone, A. Ambrosetti, L. Marcheselli, F. Rossi, S. Luminari, A. Rossi, L. Cro, M. Federico, G. Lambertenghi Deliliers, L. Baldini
Second malignancies in essential thrombocythemia (ET): a retrospective analysis of 331 patients with long-term follow-up from a single institution.
2008 F. Radaelli, F. Onida, F.G. Rossi, V.R. Zilioli, M. Colombi, P. Usardi, R. Calori, A. Zanella
Febrile Neutropenia Risk Assesment and Granulocyte-Colony Stimulating Factor Support in Patients with Diffuse Large B Cell Lymphoma Receiving R-CHOP Regimens
2009 A. Salar, C. Haioun, F. Rossi, U. Duehrsen, R. Pettengel, H.E. Johnsen, U. Jaeger, G. Verhoef, M. Schwenkglenks, F. Principe, P. Bacon, K. Bendall, P.J. Lugtemburg
Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance
2009 F. Rossi, M.T. Petrucci, A. Guffanti, L. Marcheselli, D. Rossi, V. Callea, F. Vincenzo, M. De Muro, A. Baraldi, O. Villani, P. Musto, A. Bacigalupo, G. Gaidano, G. Avvisati, M. Goldaniga, L. Depaoli, L. Baldini
Prognostic scoring system for IGG and IGA monoclonal gammopathies of undetermined significance
2009 F. Rossi, M.T. Petrucci, A. Guffanti, L. Marcheselli, D. Rossi, V. Callea, F. Vincenzo, M. De Muro, A. Baraldi, O. Villani, P. Musto, A. Bacigalupo, G. Gaidiano, G. Avvisati, M. Goldaniga, L. De Poli, L. Baldini
Frontline treatment with the combination fludarabine-cyclophosphamide in low-grade non-follicular non-Hodgkin lymphoma : a long term updating of GISL LL02 trial
2010 A. Ferrario, M. Goldaniga, F. Merli, V. Callea, F. Ilariucci, C. Stelitano, M. Russo, P. Mazza, S. Luminari, L. Marcheselli, M. Brugiatelli, D. Luisi, F. Rossi, B. Olivero, G. Lambertenghi Deliliers, M. Federico, L. Baldini
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile